EDTUTC-4 New YorkLog in Sign up

RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
stockNASDAQ

At CloseOct 5, 2026 3:59:58 PM EDT

4.79USD+16.262%(+0.67)66,872,634

4.7600Bid4.8300Ask0.0700Spread

Pre-marketOct 5, 2026 9:29:59 AM EDT

4.18USD+1.335%(+0.06)

After-hoursOct 5, 2026 4:59:30 PM EDT

4.76USD-0.626%(-0.03)

RXRX News

Day breaks

08:16 PM EDTCathie Wood’s ARK sells TWST stock, buys RXRX and NTLA ·

Investing.com

09:35 AM EDTMost shorted stocks on Wall Street ·

Seeking Alpha

10:00 AM EDTMost and least shorted mid- to mega-cap healthcare stocks at the end of September ·

Seeking Alpha

09:48 AM EDTTempus and Recursion Extend Data Partnership Through November 2029 ·

Securities.io

09:14 AM EDTTempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s RNA Foundation Model ·

Business Wire

03:10 PM EDTCatalyst Watch: Trump-Xi in DC, Meta Connect, and McDonald's Investor Day ·

Seeking Alpha

01:04 PM EDTAbCellera and Recursion Pharmaceuticals: two AI-drug stocks, two different stories ·

Investing.com

01:01 PM EDTRecursion Pharmaceuticals, Inc. (RXRX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

08:30 AM EDTAI in Pharmaceutical Market to Hit USD 48.43 Billion by 2035, Growing at 31.76% CAGR – SNS Insider ·

GlobeNewswire Inc.

06:52 AM EDTDrug Repurposing Market to Reach USD 50.91 Billion by 2035, Expanding at 3.93% CAGR | SNS Insider ·

GlobeNewswire Inc.

02:10 PM EDTThe Market Just Told You Which Layer Of AI Biology It Is Paying For ·

GlobeNewswire Inc.

12:46 PM EDTAI Poised to Reshape Blood Cancer Therapeutics as Investment Surges Past $2 Billion Across Leading Biotech and Pharma Players ·

GlobeNewswire Inc.

10:52 AM EDTAI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision Medicine ·

GlobeNewswire Inc.